secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001628280-25-053170
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q3 2025 revenue $267.8M (+240% YoY), net income $55.4M vs loss $8.8M
--------------------------------------------------------------------------------

- Total revenue $267.8M for Q3 2025, up 240% YoY; hospital division revenue $260.2M, up 263% YoY.
- Net income attributable to Nutex of $55.4M in Q3 2025 vs net loss of $8.8M in Q3 2024; diluted EPS $7.76.
- Adjusted EBITDA attributable to Nutex of $98.5M in Q3 2025 vs $9.7M in Q3 2024.
- YTD 2025: revenue $723.6M (+225%), net income $59.0M vs loss $9.5M, adjusted EBITDA $243.0M.
- Regained Nasdaq compliance on Nov 19, 2025 after filing delinquent 10-Q; matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/0001628280-25-053170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/nutx-20251119.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-053170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer